⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5202970 | 1.00 | — | — | |
| SCHEMBL528253 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL33649 | 0.98 | CRBN (0.44) | — | |
| Hydrochloric Acid SCHEMBL19347669 | 0.98 | CRBN (0.44) | — | |
| Bromide SCHEMBL3546365 | 0.98 | CRBN (0.44) | — | |
| Hydrochloric Acid SCHEMBL22720839 | 0.98 | CRBN (0.44) | — | |
| Hydrochloric Acid SCHEMBL22720671 | 0.98 | CRBN (0.44) | — | |
| Bromide SCHEMBL3545017 | 0.98 | CRBN (0.44) | — | |
| Bromide SCHEMBL5203587 | 0.98 | CRBN (0.44) | — | |
| Hydrochloric Acid SCHEMBL283133 | 0.95 | CRBN (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1353672-B1 | SYNTHESIS OF 4-AMINO-THALIDOMIDE ENANTIOMERS | CHILDRENS MEDICAL CENTER (US) | 2007-10-03 | — | — | EP | claimed |
| EP-4722219-A1 | CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION | Gan & Lee Pharmaceuticals Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| US-20260053796-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | ARVINAS OPERATIONS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-20260028354-A1 | TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | REGENT OF THE UNIV OF MICHIGAN (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260028346-A1 | BTK DEGRADER AND USE THEREOF | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2026-01-29 | — | — | US | disclosed |
| US-20260028345-A1 | BTK DEGRADER AND USE THEREOF | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2026-01-29 | — | — | US | disclosed |
| US-20260007681-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | UNIV MICHIGAN (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4652161-A1 | 2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS | Uppthera, Inc. (KR) | 2025-11-26 | — | — | EP | disclosed |
| EP-4626555-A1 | GLUTARIMIDE-CONTAINING PAN-KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | Tiger Biotherapeutics Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-4626554-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | Tiger Biotherapeutics Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20080306113-A1 | Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione | CHILDREN'S MEDICAL CENTER CORPORATION, THE | 2008-12-11 | — | — | US | disclosed |
| US-20080045557-A1 | Administering chemokine peptides, variants, and derivatives thereof, as well as chemokine peptide analogs to modulate the migration or recruitment of leukocytes to a preselected physiological site | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD. | 2008-02-21 | — | — | US | disclosed |
| EP-1353672-B1 | SYNTHESIS OF 4-AMINO-THALIDOMIDE ENANTIOMERS | CHILDRENS MEDICAL CENTER (US) | 2007-10-03 | — | — | EP | disclosed |
| US-7238711-B1 | Compounds and methods to inhibit or augment an inflammatory response | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD. (GB) | 2007-07-03 | — | — | US | disclosed |
| WO-2006081251-A2 | METHODS AND COMPOSITIONS USING 4-AMINO-2-(3-METHYL-2,6-DIOXOPIPERIDIN-3-YL)-ISOINDOLE-1-3-DIONE | CELGENE CORPORATION (US) | 2006-08-03 | — | — | WO | disclosed |
| WO-2004022536-A1 | NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LIMITED (US) | 2004-03-18 | — | — | WO | disclosed |
| US-6353084-B1 | BIODEGRADABLE POLYMER OBTAINED BY REACTING MIXTURE OF ADIPIC ACID, TEREPHTHALIC ACID AND COMPOUND CONTAINING SULFONATE GROUPS WITH MIXTURE OF DIOL, ALKANOLAMINE, DIAMINOALKANE AND BISOXAZOLINE, AND POLYHYDROXY OR POLYCARBOXYLIC ACID COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-05 | — | — | US | disclosed |
| US-6111058-A | Biodegradable polyesteramide and a process of preparing | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-29 | — | — | US | disclosed |
| US-5880220-A | POLYETHERESTERAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-09 | — | — | US | disclosed |
| US-5863991-A | Biodegradable polymers, the preparation thereof and the use thereof for the production of biodegradable moldings | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |